Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Irène
Irène Corthesy-Theulaz, Epalinges CH
| Patent application number | Description | Published |
|---|---|---|
| 20080274127 | AMINO ACID SUPPLEMENTATION FOR A HEALTHY MICROBIOTA ECOSYSTEM - The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people. | 11-06-2008 |
| 20090142375 | LIPOTEICHOIC ACID FROM LACTIC ACID BACTERIA AND ITS USE TO MODULATE IMMUNE RESPONSES MADIATED BY GRAM-NEGATIVE BACTERIA, POTENTIAL PATHOGENIC GRAM-POSITIVE BACTERIA - The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or ophtalmological applications, a food or petfood composition for modulating bacterial colonisation, immune responses and decreasing the inflammatory processes associated with bacterially-mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and oral cavity. The invention also relates to lipoteichoic acid selected thereof. | 06-04-2009 |
| 20100028316 | MODERATING THE EFFECT OF ENDOTOXINS - The present invention relates to the use of an oral composition comprising yeast extract, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as | 02-04-2010 |
Irène Corthesy-Theulaz, Epalinges CH
| Patent application number | Description | Published |
|---|---|---|
| 20100028316 | MODERATING THE EFFECT OF ENDOTOXINS - The present invention relates to the use of an oral composition comprising yeast extract, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as | 02-04-2010 |
Irène Elguidj, Neuilly FR
| Patent application number | Description | Published |
|---|---|---|
| 20100150853 | Artificially coloring the skin with a carotene compound, a xanthophyll compound and a lipophilic green dye composition - A method for artificially coloring the skin entails topical application thereon of a composition containing, formulated into a physiologically acceptable medium: | 06-17-2010 |
Irène Elguidj, Neuilly FR
| Patent application number | Description | Published |
|---|---|---|
| 20100150853 | Artificially coloring the skin with a carotene compound, a xanthophyll compound and a lipophilic green dye composition - A method for artificially coloring the skin entails topical application thereon of a composition containing, formulated into a physiologically acceptable medium: | 06-17-2010 |
Irène Tatischeff, Orsay FR
| Patent application number | Description | Published |
|---|---|---|
| 20100178702 | EXTRACELLULAR VESICLES FROM NON-PATHOGENIC AMOEBAE USEFUL AS VEHICLE FOR TRANSFERRING A MOLECULE OF INTEREST TO AN EUKARYOTIC CELL - The invention relates to membrane vesicles from non-pathogenic amoeba, in particular from the amoeba | 07-15-2010 |
Irène Tatischeff, Orsay FR
| Patent application number | Description | Published |
|---|---|---|
| 20100178702 | EXTRACELLULAR VESICLES FROM NON-PATHOGENIC AMOEBAE USEFUL AS VEHICLE FOR TRANSFERRING A MOLECULE OF INTEREST TO AN EUKARYOTIC CELL - The invention relates to membrane vesicles from non-pathogenic amoeba, in particular from the amoeba | 07-15-2010 |